Applicability of TiO2(B) nanosheets@hydrochar composites for adsorption of tetracycline (TC) from contaminated water.

We test the feasibility of TiO2(B)@carbon composites as adsorbents, derived from wheat straws, for tetracycline (TC) adsorption from aqueous solutions. Hydrochar (HC), biochar (BC), and hydrochar-derived pyrolysis char (HDPC) are synthesized hydrothermally from the waste and then functionalized with TiO2(B), named as 'Composite-1', 'Composite-2', and 'Composite-3', respectively. A higher loading of TiO2(B) into the HC was also synthesized for comparison, named as 'Composite-4'. To compare their physico-chemical changes before and after surface modification, the composites are characterized using FESEM-EDS, XRD, BET, FRTEM, and FTIR. The effects of H2O2 addition on TC removal are investigated. Adsorption kinetics and isotherms of TC removal are studied, while TC adsorption mechanisms are elaborated. We found that the Composite-4 has the highest TC removal (93%) at pH 7, 1 g/L of dose, and 4 h of reaction time at 50 mg/L of TC after adding H2O2 (10 mM). The TC adsorption capacities of the Composite-1 and Composite-4 are 40.65 and 49.26 mg/g, respectively. The TC removal by the Composite-1 follows the pseudo-second order. Overall, this suggests that converting the wheat straw into HC and then functionalizing its surface with TiO2(B) as a composite has added values to the waste as an adsorbent for wastewater treatment.

Research progress on film forming materials for liquid band-aid / 药学实践杂志

Liquid band-aid is a new type of wound dressing that has emerged in recent years. Compared with traditional band-aid, it has the advantages of convenient use, natural shedding, good waterproof and breathable effect, and easy fitting for irregular wounds. It has brought a great convenience to the wound treatment in our daily life. This paper reviews the current research status of liquid band-aids at home and abroad and summarizes the research progress on film forming materials for liquid band-aids with the purpose to provide references for the further development and improvement of liquid band-aids.

Study on sirolimus solubilization technology based on in vitro dissolution and in vivo bioavailability / 药学实践杂志

Objective To evaluate the effects of different solubilizing techniques on the in vitro dissolution and in vivo pharmacokinetics of Sirolimus (SRL). Methods Solid dispersions (SD), inclusion complex (IC), self-micro emulsifying drug delivery system (SMEDDS) and nano-structured lipid carrier (NLC) were selected as the solubilization technology for SRL. SRL-SMEDDS and SRL-NLC have obtained the optimal prescription in the previous studies. Additionally, the formulation process of SRL-SD and SRL-IC was screened by using inclusion rate and dissolution profiles as indicators. 0.4% SDS, water and buffer solutions with pH 1.2, 4.5, 6.8, 7.4 were used as dissolution media. The dissolution profile of the commercially available formulation Rapamune® and the lab-made solubilized preparations were investigated. The in vivo absorption of the above preparations was examined using a pharmacokinetic test in Beagle dogs. Results In 0.4% SDS, the dissolution of each preparation exceeded 80% in 2 h. In the medium of pH 1.2, the dissolution of SRL-SD could not be measured while the dissolution of IC, SMEDDS and NLC increased first and then decreased. In other media, the dissolution of the SRL was reduced. The SRL-IC showed the best dissolution without a significant decrease. The relative bioavailability of APIs, SRL-SD, SRL-IC, SRL-NLC and SRL-SMEDDS were 9.1%, 18.7%, 33.2%, 78.0%, and 97.6% respectively in vivo pharmacokinetic tests. Conclusion SD, SMEDDS, NLC, and IC can improve the in vitro dissolution and in vivo absorption of SRL. Among them, SMEDDS has the most significant improvement in the bioavailability of SRL.

Risk management of medication in transitional care / 中国临床药理学与治疗学

Transitional care is an important step in the process of treating disease. Medication risk during this period of time has become a public safety issue and attracted more attention. It not only threatens patients' health, but also increases the unnecessary cost of medical resources. Through systematically analyzing the medication risk in each link of the transition care, this paper discusses the strategies to improve the medication risk management of patients in the process of transition, and provides references for improving the level of rational medication use and optimizing the allocation of medical resources in transition care.

Optimization of formulation process and in vitro evaluation of copper sulfide nanoparticles / 药学实践杂志

Objective To avoid the accumulation of copper sulfide (CuS) nanoparticles, prepare and optimize CuS nanoparticles, analyze the factors affecting the particle size and evaluate their photothermal properties. Methods Based on the single factor study, central composite design-response surface methodology was used to optimize the CuS nanoparticle formulation process. The morphology, particle size stability, photothermal conversion efficiency, photothermal stability of optimized CuS nanoparticles were characterized. The toxicity of CuS nanoparticles on 4T1 breast cancer cells and HK2 kidney cells was evaluated by CCK-8 method. In vitro photothermal experiment was used to investigate the ability of CuS nanoparticles on killing 4T1 breast cancer cells. Results The average hydration dynamic diameter of optimized CuS nanoparticles was (10.53±1.63)nm, the actual particle size of CuS nanoparticles showed by TEM image was (3.10±0.81)nm. It had good particle size stability, good photothermal conversion efficiency and photothermal stability. Within the concentration range of 100 μg/ml and 150 μg/ml，it showed no significant toxicity on 4T1 breast cancer cells and HK2 kidney cells, indicating the good stability of CuS nanoparticles. In vitro photothermal therapy showed that CuS nanoparticles had good ability to kill 4T1 breast cancer cells by photothermal. Conclusion The prepared CuS nanoparticles have a small particle size (less than 6nm) and a good photothermal effect, which is expected to solve the problem of CuS nanoparticles accumulation in vivo and make it better for tumor treatment.